Application of BP neural networks in pharmaceutical enterprise's performance evaluation:taking launched pharmaceutical company of Chinese patent drugs for exampleCHU Shu-zhen, YANG Jia-xin1925-1929
The incentive effect of exclusive market interests on pharmaceutical enterprisesYIN Tian-hong, YAN Jian-zhou, SHAO Rong1930-1934
Statistical analysis of invalid patents of 23 universities of traditional Chinese medicineYU Xiao-yong, TIAN Kan, WANG Zhi-gang1935-1940
Moral hazard assessment of R&D outsourcing and control of CRO enterprisesNI Fei, WEI Hua1941-1946,1962
Screening of novel antitubercular drugs targeting IspDLU Zhong-yang, YANG Yan-hui, MENG Jian-zhou, GUAN Yan, HAO Xue-qin, XIAO Chun-ling1947-1953
Progress of cell models for liver toxicity evaluation in vitro李曼, 董延生, 李泽君, 谢丽华, 樊星, 呼丹, 刘悦, 吴纯启, 廖明阳1954-1958,1974
Development of a method for determination of potency of anti-IL-1β monoclonal antibody刘春雨, 徐刚领, 于传飞, 张峰, 王文波, 李萌, 陈伟, 王兰, 高凯1959-1962
In vivo bioactivity of recombinant human follicle-stimulating hormone and its effect on superovulation in immature ratsCHENG Su-yuan, WANG Jun-ling, LI Xin-xin, WU Yan-zhuo, LIANG Cheng-gang, LI Zhan-jun1963-1967
Research and analysis on corrective and preventive action of Chinese pharmaceutical enterprisesZHANG Li-ying, ZHENG Qiang1968-1974